Article
Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced…
Cancer Management and Research · 2019 · Liang H, Wang M
Key facts
| Title | Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer |
|---|---|
| First author | Liang H, Wang M |
| Journal | Cancer Management and Research |
| Published | Aug 15, 2019 |
| DOI | 10.2147/CMAR.S212238 |
| Devices mentioned | 212238, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 2 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1